Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05577182
Title Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Incyte Corporation
Age Groups: senior | adult
Covered Countries USA | ESP | BEL

Additional content available in CKB BOOST